Acute exacerbation of idiopathic pulmonary fibrosis has been defined as an acute, clinically
significant, respiratory deterioration of unidentifiable cause. The objective of this …

Background Idiopathic pulmonary fibrosis (IPF) is a progressive debilitating lung disease
with considerable morbidity. Heterogeneity in epidemiologic studies means the full impact of …

… Maher has received grants and personal fees from GlaxoSmithKline R&D and AstraZeneca,
and personal fees from Boehringer Ingelheim, Roche, Bayer, Samumed, Galapagos, …

Background: This American Thoracic Society, European Respiratory Society, Japanese
Respiratory Society, and Asociación Latinoamericana de Tórax guideline updates prior …

… Group comparisons were made using Student's t test, Wilcoxon rank sum, χ 2 statistics and
Fisher's exact test, as appropriate. A P value of less than 0.05 was considered significant. …

Background Interstitial lung disease (ILD) is a common manifestation of systemic sclerosis
and a leading cause of systemic sclerosis–related death. Nintedanib, a tyrosine kinase …

We performed a genome-wide association study of non-Hispanic, white individuals with fibrotic
idiopathic interstitial pneumonias (IIPs; n = 1,616) and controls (n = 4,683), with follow-up …

Importance Administration of hydroxychloroquine with or without azithromycin for the treatment
of coronavirus disease 2019 (COVID-19)–associated pneumonia carries increased risk of …

As of May 6, 2020, nearly 3· 7 million people have been infected and around 260 000 people
have died from coronavirus disease 2019 (COVID-19) worldwide. 1 Almost all COVID-19-…

Objective. —Almost all males with cystic fibrosis (CF) have absent vasa deferentia. It has
been suggested that otherwise healthy males with congenital bilateral absence of the vas …